Efforts to define and measure outcomes that recognize quality palliative care across diseases have been significant. In the field of oncology, greater emphasis has been placed on patients with solid tumors, with less evidence available about those with hematologic malignancies. A recent article reported on adherence priorities utilized by palliative care clinicians caring for both cancer groups.
Medscape